Skip to main content

Table 3 Blood test result on admission of case 3

From: Drug-induced interstitial lung disease caused by olaparib: three case reports and review of the Japanese Adverse Drug Event Report database and literature

Laboratory findings

 

Reference value

WBC (×103/μL)WBC (×103/μL)

2.9

3.3 - 8.6

Seg (%)

81

38 - 74

Lymph (%)

16

16.5 - 49.5

Mono (%)

2.4

2 - 10

Eosino (%)

0.3

0 - 8.5

RBC (×106μL)RBC (×106μL)

1.78

4.35 - 5.55

Hg (g/dL)

5.3

13.7 - 16.8

Hct (%)

15.4

40.7 - 50.1

Plt (μL)

70

158 - 348

TP (g/dL)

5.8

6.6 - 8.1

Alb (g/dL)

3

4.1 - 5.1

AST (IU/L)

22

13 - 30

ALT (IU/L)

8

10 - 42

LDH (IU/L)

309

124 - 222

BUN (mg/dL)

24

8 - 20

Cr (mg/dL)

1.02

0.65 - 1.07

CRP (mg/dL)

10.82

0.00 - 0.14

KL-6 (U/mL)

356

105.3 - 401.2

SP-A (ng/mL)

140.2

< 43.8

SP-D (ng/mL)

231

< 110

Anti-nuclear antibodies (n times)

< 80

< 80

Anti-ARS antibody (INDEX)

< 5.0

< 25

Anti-CCP antibody (U/mL)

< 0.6

< 4.5

Anti-SS-A antibody (U/mL)

1

< 10

Anti-SS-B antibody (U/mL)

< 1.0

< 10

MPO-ANCA (U/mL)

< 1.0

< 3.5

PR3-ANCA (U/mL)

< 1.0

< 3.5

Procalcitonin (ng/mL)

0.136

< 0.05

Beta D-Glucan (pg/mL)

5.5

< 20

Cytomegalovirus antigen C7HRP

negative